TSA promotes epithelial mesenchymal transition (EMT) in ESCC cells by downregulating the epithelial marker E-cadherin and upregulating the mesenchymal markers β - catenin, vimentin, Slug, and PAI-1. The gene discussed is SNAI2; the disease is esophageal squamous cell carcinoma.